<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="fe0f5dcb-65dd-4d31-80d6-8b97eb040063"><labelDrug name="Catapres"><Normalization/></labelDrug><generic name="clonidine"/><sentence id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.1" text="CATAPRES (clonidine) patch, extended release" type="negative"><entity charOffset="0:8" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.1.e.0" text="catapres" type="Biomedical_Entity"><Normalization><mmtx cui="C0699881" phraseText="CATAPRES" preferredWord="Catapres" semType="phsu, orch"/><RxNorm RxCui="202941"/></Normalization></entity><entity charOffset="10:19" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.1.e.1" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="(clonidine" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.1.e.0" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.1.e.1"/></sentence><sentence id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.2" text="CATAPRES-TTS (clonidine) is a transdermal system providing continuous systemic delivery of clonidine for 7 days at an approximately constant rate." type="negative"><entity charOffset="91:100" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.2.e.0" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="continuous systemic delivery of clonidine" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="14:23" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.2.e.1" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="CATAPRES-TTS (clonidine" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="0:12" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.2.e.2" text="catapres-tts" type="Biomedical_Entity"><Normalization><mmtx cui="C0917969" phraseText="CATAPRES-TTS (clonidine" preferredWord="Catapres-TTS" semType="phsu, orch"/><RxNorm RxCui="215919"/></Normalization></entity><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.2.e.2" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.2.e.0"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.2.e.2" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.2.e.1"/></sentence><sentence id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.4" text="CATAPRES-TTS transdermal therapeutic system should not be used in patients with known hypersensitivity to clonidine or to any other component of the therapeutic system." type="negative"><entity charOffset="0:12" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.4.e.0" text="catapres-tts" type="Biomedical_Entity"><Normalization><mmtx cui="C0917969" phraseText="CATAPRES-TTS transdermal therapeutic system" preferredWord="Catapres-TTS" semType="phsu, orch"/><RxNorm RxCui="215919"/></Normalization></entity><entity charOffset="106:115" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.4.e.1" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="to clonidine" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.4.e.0" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.4.e.1"/></sentence><sentence id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.8" text="Sudden cessation of clonidine treatment has, in some cases, resulted in symptoms such as nervousness, agitation, headache, tremor, and confusion accompanied or followed by a rapid rise in blood pressure and elevated catecholamine concentrations in the plasma. " type="negative"><entity charOffset="216:229" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.8.e.0" text="catecholamine" type="Biomedical_Entity"><Normalization><mmtx cui="C0007412" phraseText="elevated catecholamine concentrations in the plasma." preferredWord="Catecholamines" semType="phsu, nsba"/><RxNorm RxCui="2146"/></Normalization></entity><entity charOffset="20:29" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.8.e.1" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="Sudden cessation of clonidine treatment" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.8.e.1" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.8.e.0"/></sentence><sentence id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.9" text="The likelihood of such reactions to discontinuation of clonidine therapy appears to be greater after administration of higher doses or continuation of concomitant beta-blocker treatment and special caution is therefore advised in these situations. " type="negative"><entity charOffset="55:64" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.9.e.0" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="of clonidine therapy" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="163:175" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.9.e.1" text="beta-blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="continuation of concomitant beta-blocker treatment" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.9.e.0" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.9.e.1"/></sentence><sentence id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.12" text="An excessive rise in blood pressure following discontinuation of CATAPRES-TTS transdermal therapeutic system therapy can be reversed by administration of oral clonidine hydrochloride or by intravenous phentolamine. " type="negative"><entity charOffset="201:213" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.12.e.0" text="phentolamine" type="Biomedical_Entity"><Normalization><mmtx cui="C0031448" phraseText="or by intravenous phentolamine." preferredWord="Phentolamine" semType="phsu, orch"/><RxNorm RxCui="8153"/></Normalization></entity><entity charOffset="159:182" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.12.e.1" text="clonidine hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0546860" phraseText="reversed by administration of oral clonidine hydrochloride" preferredWord="Clonidine Hydrochloride" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="65:77" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.12.e.2" text="catapres-tts" type="Biomedical_Entity"><Normalization><mmtx cui="C0917969" phraseText="discontinuation of CATAPRES-TTS transdermal therapeutic system therapy" preferredWord="Catapres-TTS" semType="phsu, orch"/><RxNorm RxCui="215919"/></Normalization></entity><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.12.e.1" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.12.e.0"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.12.e.2" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.12.e.0"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.12.e.2" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.12.e.1"/></sentence><sentence id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.13" text="If therapy is to be discontinued in patients receiving a beta-blocker and clonidine concurrently, the beta-blocker should be withdrawn several days before the gradual discontinuation of CATAPRES-TTS transdermal therapeutic system." type="negative"><entity charOffset="57:69" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.13.e.0" text="beta-blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="a beta-blocker" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="102:114" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.13.e.1" text="beta-blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="the beta-blocker" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="74:83" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.13.e.2" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="clonidine concurrently," preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="186:198" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.13.e.3" text="catapres-tts" type="Biomedical_Entity"><Normalization><mmtx cui="C0917969" phraseText="several days before the gradual discontinuation of CATAPRES-TTS transdermal therapeutic system." preferredWord="Catapres-TTS" semType="phsu, orch"/><RxNorm RxCui="215919"/></Normalization></entity><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.13.e.0" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.13.e.2"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.13.e.0" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.13.e.3"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.13.e.2" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.13.e.1"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.13.e.1" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.13.e.3"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.13.e.2" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.13.e.3"/></sentence><sentence id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.16" text="In patients who have developed localized contact sensitization to CATAPRES-TTS  (clonidine) transdermal therapeutic system continuation of CATAPRES-TTS transdermal therapeutic system or substitution of oral clonidine hydrochloride therapy may be associated with development of a generalized skin rash." type="negative"><entity charOffset="66:78" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.16.e.0" text="catapres-tts" type="Biomedical_Entity"><Normalization><mmtx cui="C0917969" phraseText="contact sensitization to CATAPRES-TTS  (clonidine" preferredWord="Catapres-TTS" semType="phsu, orch"/><RxNorm RxCui="215919"/></Normalization></entity><entity charOffset="139:151" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.16.e.1" text="catapres-tts" type="Biomedical_Entity"><Normalization><mmtx cui="C0917969" phraseText="transdermal therapeutic system continuation of CATAPRES-TTS transdermal therapeutic system" preferredWord="Catapres-TTS" semType="phsu, orch"/><RxNorm RxCui="215919"/></Normalization></entity><entity charOffset="207:230" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.16.e.2" text="clonidine hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0546860" phraseText="substitution of oral clonidine hydrochloride therapy" preferredWord="Clonidine Hydrochloride" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="81:90" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.16.e.3" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="contact sensitization to CATAPRES-TTS  (clonidine" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.16.e.0" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.16.e.2"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.16.e.0" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.16.e.3"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.16.e.1" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.16.e.2"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.16.e.3" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.16.e.1"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.16.e.3" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.16.e.2"/></sentence><sentence id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.17" text="In patients who develop an allergic reaction to CATAPRES-TTS transdermal therapeutic system, substitution of oral clonidine hydrochloride may also elicit an allergic reaction (including generalized rash, urticaria, or angioedema)." type="negative"><entity charOffset="48:60" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.17.e.0" text="catapres-tts" type="Biomedical_Entity"><Normalization><mmtx cui="C0917969" phraseText="an allergic reaction to CATAPRES-TTS transdermal therapeutic system," preferredWord="Catapres-TTS" semType="phsu, orch"/><RxNorm RxCui="215919"/></Normalization></entity><entity charOffset="114:137" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.17.e.1" text="clonidine hydrochloride" type="Biomedical_Entity"><Normalization><mmtx cui="C0546860" phraseText="substitution of oral clonidine hydrochloride" preferredWord="Clonidine Hydrochloride" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.17.e.0" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.17.e.1"/></sentence><sentence id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.18" text="The sympatholytic action of clonidine may worsen sinus node dysfunction and atrioventricular (AV) block, especially in patients taking other sympatholytic drugs. " type="negative"><entity charOffset="28:37" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.18.e.0" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="The sympatholytic action of clonidine" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="141:160" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.18.e.1" text="sympatholytic drugs" type="Biomedical_Entity"><Normalization><mmtx cui="C0039051" phraseText="other sympatholytic drugs." preferredWord="Sympatholytics" semType="phsu"/><RxNorm RxCui="10281"/></Normalization></entity><entity charOffset="4:17" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.18.e.2" text="sympatholytic" type="Biomedical_Entity"><Normalization><mmtx cui="C0039051" phraseText="The sympatholytic action of clonidine" preferredWord="Sympatholytics" semType="phsu"/><RxNorm RxCui="10281"/></Normalization></entity><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.18.e.0" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.18.e.1"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.18.e.2" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.18.e.0"/></sentence><sentence id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.19" text="There are post-marketing reports of patients with conduction abnormalities and/or taking other sympatholytic drugs who developed severe bradycardia requiring IV atropine, IV isoproterenol and temporary cardiac pacing while taking clonidine." type="negative"><entity charOffset="161:169" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.19.e.0" text="atropine" type="Biomedical_Entity"><Normalization><mmtx cui="C0004259" phraseText="severe bradycardia requiring IV atropine," preferredWord="Atropine" semType="phsu, orch"/><RxNorm RxCui="1223"/></Normalization></entity><entity charOffset="95:114" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.19.e.1" text="sympatholytic drugs" type="Biomedical_Entity"><Normalization><mmtx cui="C0039051" phraseText="other sympatholytic drugs" preferredWord="Sympatholytics" semType="phsu"/><RxNorm RxCui="10281"/></Normalization></entity><entity charOffset="230:239" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.19.e.2" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="taking clonidine." preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="174:187" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.19.e.3" text="isoproterenol" type="Biomedical_Entity"><Normalization><mmtx cui="C0022245" phraseText="IV isoproterenol" preferredWord="Isoproterenol" semType="phsu, orch"/><RxNorm RxCui="82030"/></Normalization></entity><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.19.e.1" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.19.e.0"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.19.e.0" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.19.e.2"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.19.e.0" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.19.e.3"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.19.e.1" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.19.e.2"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.19.e.1" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.19.e.3"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.19.e.3" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.19.e.2"/></sentence><sentence id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.25" text="Physicians considering starting CATAPRES-TTS transdermal therapeutic system therapy during the perioperative period must be aware that therapeutic plasma clonidine levels are not achieved until 2 to 3 days after initial application of Catapres-TTS transdermal therapeutic system (see DOSAGE AND ADMINISTRATION)." type="negative"><entity charOffset="32:44" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.25.e.0" text="catapres-tts" type="Biomedical_Entity"><Normalization><mmtx cui="C0917969" phraseText="starting CATAPRES-TTS transdermal therapeutic system therapy during the perioperative period" preferredWord="Catapres-TTS" semType="phsu, orch"/><RxNorm RxCui="215919"/></Normalization></entity><entity charOffset="235:247" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.25.e.1" text="catapres-tts" type="Biomedical_Entity"><Normalization><mmtx cui="C0917969" phraseText="of Catapres-TTS transdermal therapeutic system" preferredWord="Catapres-TTS" semType="phsu, orch"/><RxNorm RxCui="215919"/></Normalization></entity><entity charOffset="154:163" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.25.e.2" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="that therapeutic plasma clonidine levels" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.25.e.0" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.25.e.2"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.25.e.2" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.25.e.1"/></sentence><sentence biomedicalEntities="4" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29" lineNumber="41" text="Clonidine may potentiate the CNS-depressive effects of alcohol, barbiturates or other sedating drugs. " type="regular"><entity charOffset="0:9" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29.e.0" text="Clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="Clonidine" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="14:51" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29.e.1" text="potentiate the CNS-depressive effects" type="Specific_Interaction"/><entity charOffset="55:62" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29.e.3" text="alcohol" type="Substance"><Normalization><RxNorm RxCui="448"/></Normalization></entity><entity charOffset="64:76" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29.e.4" text="barbiturates" type="Drug_Class"><Normalization><mmtx cui="C0004745" phraseText="barbiturates" preferredWord="Barbiturates" semType="phsu, orch"/><RxNorm RxCui="1437144"/></Normalization></entity><entity charOffset="86:100" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29.e.5" text="sedating drugs" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="other sedating drugs." preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="107777"/></Normalization></entity><classClassMembership drugClass="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29.e.4"/><drugInteraction id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29.ddi.1"><interaction trigger="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29.e.1"><relations><relation type="hasObject"><entity id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29.e.0" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29.e.3" trigger="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29.e.0" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29.e.4" trigger="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29.e.0" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29.e.5" trigger="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.29.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.30" lineNumber="41" text="If a patient receiving clonidine is also taking tricyclic antidepressants, the hypotensive effect of clonidine may be reduced, necessitating an increase in the clonidine dose. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="101:110" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.30.e.4" text="clonidine" type="Drug"/><antecedentEntity charOffset="23-32" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.30.e.0" text="clonidine" type="Drug"/></anaphoraRelation><entity charOffset="23:32" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.30.e.0" text="clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="a patient receiving clonidine" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="48:73" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.30.e.1" text="tricyclic antidepressants" type="Drug_Class"><Normalization><mmtx cui="C0003290" phraseText="tricyclic antidepressants," preferredWord="Tricyclic Antidepressive Agents" semType="phsu"/><RxNorm RxCui="928"/></Normalization></entity><entity charOffset="79:97|118:125" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.30.e.2" text="hypotensive effect reduced" type="Specific_Interaction"/><entity charOffset="101:110" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.30.e.4" text="clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="the hypotensive effect of clonidine" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><drugInteraction id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.30.ddi.1"><interaction trigger="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.30.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.30.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.30.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.30.e.1" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.30.e.4" trigger="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.30.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.31" lineNumber="41" text="If a patient receiving clonidine is also taking neuroleptics, orthostatic regulation disturbances (e.g., orthostatic hypotension, dizziness, fatigue) may be induced or exacerbated." type="regular"><entity charOffset="23:32" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.31.e.0" text="clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="a patient receiving clonidine" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="48:60" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.31.e.1" text="neuroleptics" type="Drug_Class"><Normalization><mmtx cui="C0040615" phraseText="also taking neuroleptics," preferredWord="Antipsychotic Agents" semType="phsu"/><RxNorm RxCui="10693"/></Normalization></entity><entity charOffset="62:97" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.31.e.2" text="orthostatic regulation disturbances" type="Specific_Interaction"><Normalization><mmtx cui="C0149746" phraseText="orthostatic regulation disturbances" preferredWord="Orthostasis" semType="sosy"/></Normalization></entity><drugInteraction id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.31.ddi.1"><interaction trigger="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.31.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.31.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.31.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.31.e.0" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.31.e.1" trigger="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.31.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="5" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.32" lineNumber="43" text="Monitor heart rate in patients receiving clonidine concomitantly with agents known to affect sinus node function or AV nodal conduction e.g., digitalis, calcium channel blockers, and beta-blockers. " type="regular"><entity charOffset="0:7" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.32.e.0" text="Monitor" type="Caution_Interaction"/><entity charOffset="41:50" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.32.e.2" text="clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="clonidine concomitantly with agents" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="70:135" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.32.e.3" text="agents known to affect sinus node function or AV nodal conduction" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="clonidine concomitantly with agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="126263"/></Normalization></entity><entity charOffset="142:151" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.32.e.4" text="digitalis" type="Drug"><Normalization><mmtx cui="C0304520" phraseText="digitalis," preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="153:177" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.32.e.5" text="calcium channel blockers" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="calcium channel blockers," preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="183:196" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.32.e.6" text="beta-blockers" type="Drug_Class"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><drugClassMembership drug="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.32.e.4" drugClass="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.32.e.3"/><classClassMembership drugClass="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.32.e.5"/><classClassMembership drugClass="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.32.e.6"/><drugInteraction id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.32.ddi.1"><interaction trigger="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.32.e.0"><relations><relation type="hasObject"><entity id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.32.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.32.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.32.e.2" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.32.e.3" trigger="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.32.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="3" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.33" lineNumber="43" text="Sinus bradycardia resulting in hospitalization and pacemaker insertion has been reported in association with the use of clonidine concomitantly with diltiazem or verapamil." type="regular"><entity charOffset="0:17" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.33.e.0" text="Sinus bradycardia" type="Specific_Interaction"/><entity charOffset="120:129" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.33.e.2" text="clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="of clonidine concomitantly" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="149:158" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.33.e.3" text="diltiazem" type="Drug"><Normalization><mmtx cui="C0012373" phraseText="with diltiazem" preferredWord="Diltiazem" semType="phsu, orch"/><RxNorm RxCui="203211"/></Normalization></entity><entity charOffset="162:171" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.33.e.4" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="verapamil." preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><drugInteraction id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.33.ddi.1"><interaction trigger="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.33.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.33.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.33.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.33.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.33.e.2" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.33.e.4" trigger="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.33.e.0" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.33.e.2" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.33.e.3" trigger="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.33.e.0" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.33.e.3" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.33.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.34" lineNumber="45" text="Amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats (see Toxicology)." type="regular"><entity charOffset="0:13" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.34.e.0" text="Amitriptyline" type="Drug"><Normalization><mmtx cui="C0002600" phraseText="Amitriptyline in combination" preferredWord="Amitriptyline" semType="phsu, orch"/><RxNorm RxCui="704"/></Normalization></entity><entity charOffset="34:43" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.34.e.1" text="clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="with clonidine" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="74:89" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.34.e.2" text="corneal lesions" type="Specific_Interaction"/><entity charOffset="90:97" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.34.e.4" text="in rats" type="SPAN"/><drugInteraction id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.34.ddi.1"><interaction trigger="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.34.e.2"><relations><relation type="hasEvidence"><entity id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.34.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.34.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.34.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.34.e.0" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.34.e.1" evidence="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.34.e.4" trigger="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.34.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.41" lineNumber="53" text="In combination with amitriptyline, clonidine hydrochloride administration led to the development of corneal lesions in rats within 5 days." type="regular"><entity charOffset="20:33" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.41.e.0" text="amitriptyline" type="Drug"><Normalization><mmtx cui="C0002600" phraseText="with amitriptyline," preferredWord="Amitriptyline" semType="phsu, orch"/><RxNorm RxCui="704"/></Normalization></entity><entity charOffset="35:58" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.41.e.1" text="clonidine hydrochloride" type="Drug"><Normalization><mmtx cui="C0546860" phraseText="clonidine hydrochloride administration" preferredWord="Clonidine Hydrochloride" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="100:115" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.41.e.2" text="corneal lesions" type="Specific_Interaction"/><entity charOffset="116:123" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.41.e.4" text="in rats" type="SPAN"/><drugInteraction id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.41.ddi.1"><interaction trigger="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.41.e.2"><relations><relation type="hasObject"><entity id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.41.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.41.e.0"/></relation><relation type="hasEvidence"><entity id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.41.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.41.e.0" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.41.e.1" evidence="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.41.e.4" trigger="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.41.e.2" type="Specific_Interaction"/></sentence><sentence id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.43" text="Apply CATAPRES-TTS (clonidine) transdermal therapeutic system once every 7 days to a hairless area of intact skin on the upper outer arm or chest. " type="negative"><entity charOffset="20:29" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.43.e.0" text="clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C0009014" phraseText="CATAPRES-TTS (clonidine" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="6:18" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.43.e.1" text="catapres-tts" type="Biomedical_Entity"><Normalization><mmtx cui="C0917969" phraseText="CATAPRES-TTS (clonidine" preferredWord="Catapres-TTS" semType="phsu, orch"/><RxNorm RxCui="215919"/></Normalization></entity><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.43.e.1" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.43.e.0"/></sentence><sentence id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.47" text="To initiate therapy, CATAPRES-TTS transdermal therapeutic system dosage should be titrated according to individual therapeutic requirements, starting with CATAPRES-TTS-1. " type="negative"><entity charOffset="155:169" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.47.e.0" text="catapres-tts-1" type="Biomedical_Entity"><Normalization><mmtx cui="C0719188" phraseText="starting with CATAPRES-TTS-1." preferredWord="Catapres-TTS-1" semType="phsu, orch"/><RxNorm RxCui="215917"/></Normalization></entity><entity charOffset="21:33" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.47.e.1" text="catapres-tts" type="Biomedical_Entity"><Normalization><mmtx cui="C0917969" phraseText="CATAPRES-TTS transdermal therapeutic system dosage" preferredWord="Catapres-TTS" semType="phsu, orch"/><RxNorm RxCui="215919"/></Normalization></entity><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.47.e.1" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.47.e.0"/></sentence><sentence id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50" text="When substituting CATAPRES-TTS transdermal therapeutic system for oral clonidine or for other antihypertensive drugs, physicians should be aware that the antihypertensive effect of CATAPRES-TTS transdermal therapeutic system may not commence until 2-3 days after initial application. " type="negative"><entity charOffset="31:80" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50.e.0" text="transdermal clonidine" type="Biomedical_Entity"><Normalization><mmtx cui="C1270887" phraseText="CATAPRES-TTS transdermal therapeutic system for oral clonidine" preferredWord="Transdermal clonidine" semType="phsu, orch"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="181:193" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50.e.1" text="catapres-tts" type="Biomedical_Entity"><Normalization><mmtx cui="C0917969" phraseText="the antihypertensive effect of CATAPRES-TTS transdermal therapeutic system" preferredWord="Catapres-TTS" semType="phsu, orch"/><RxNorm RxCui="215919"/></Normalization></entity><entity charOffset="18:30" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50.e.2" text="catapres-tts" type="Biomedical_Entity"><Normalization><mmtx cui="C0917969" phraseText="CATAPRES-TTS transdermal therapeutic system for oral clonidine" preferredWord="Catapres-TTS" semType="phsu, orch"/><RxNorm RxCui="215919"/></Normalization></entity><entity charOffset="154:170" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50.e.3" text="antihypertensive" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="the antihypertensive effect of CATAPRES-TTS transdermal therapeutic system" preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><entity charOffset="94:116" id="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50.e.4" text="antihypertensive drugs" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="or for other antihypertensive drugs," preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50.e.0" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50.e.1"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50.e.2" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50.e.0"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50.e.0" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50.e.3"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50.e.0" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50.e.4"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50.e.3" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50.e.1"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50.e.4" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50.e.1"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50.e.2" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50.e.3"/><pair ddi="false" e1="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50.e.2" e2="Dailymed.fe0f5dcb-65dd-4d31-80d6-8b97eb040063.s.50.e.4"/></sentence><positiveExamples number="10"/><negativeExamples number="41"/></document>